Pfizer-BioNTech testing booster of their COVID-19 vaccine in new trial

Pfizer and BioNTech are testing a third dose of their COVID-19 vaccine to better understand the immune response against new variants of the virus. In the first stage, a third dose will be given to up to 144 people who received the vaccine in the original Phase I safety trial.

Reuters Health